Mellow Bumps RCT - Antenatal Intervention for Vulnerable Women
Launched by UNIVERSITY OF GLASGOW · May 1, 2012
Trial Information
Current as of May 08, 2025
Completed
Keywords
ClinConnect Summary
Lower than anticipated recruitment numbers have resulted in changes to the planned methodology of this trial. Firstly, participants were allocated to the three arms in groups/blocks of 6. Secondly, randomisation of the final group recruited was abandoned.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • pregnant, between 20 \& 30 weeks gestation at start of intervention
- • Identified by midwives as meeting Special Needs in Pregnancy (SNiP) criteria
- • basic understanding of written and spoken English
- Exclusion Criteria:
- • not identified as vulnerable through SNiP criteria
- • less than 20 weeks or more than 30 weeks gestation at start of intervention
About University Of Glasgow
The University of Glasgow is a prestigious academic institution renowned for its commitment to advancing medical research and improving healthcare outcomes. As a clinical trial sponsor, the university leverages its extensive expertise in various fields of medicine and health sciences to design and conduct innovative clinical trials. With a strong focus on ethical standards and patient safety, the University of Glasgow collaborates with multidisciplinary teams and partners to translate research findings into practical applications, fostering advancements in medical knowledge and therapeutic interventions. Its dedication to excellence in research and education positions the university as a leader in clinical trial initiatives that aim to address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Greenock, Inverclyde, United Kingdom
Irvine, North Ayrshire, United Kingdom
Patients applied
Trial Officials
Philip Wilson
Principal Investigator
University of Glasgow
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials